MENU
+Compare
BBC
ETF ticker: NYSE ARCA
AS OF
Nov 13, 03:54 PM (EDT)
Price
$31.55
Change
-$0.70 (-2.17%)
Net Assets
20.96M

BBC stock forecast, quote, news & analysis

The investment seeks investment results that correspond, before fees and expenses, to the price and yield performance of the LifeSci Biotechnology Clinical Trials Index... Show more

Category: #Health
BBC
Daily Signal:
Gain/Loss:
A.I.Advisor
published price charts
These past five trading days, the ETF lost 0.00% with an average daily volume of 0 shares traded.The ETF tracked a drawdown of 0% for this period.
Interact to see
Advertisement
A.I.Advisor
a Summary for BBC with price predictions
Nov 12, 2025

Aroon Indicator for BBC shows an upward move is likely

BBC's Aroon Indicator triggered a bullish signal on November 10, 2025. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 186 similar instances where the Aroon Indicator showed a similar pattern. In of the 186 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on November 12, 2025. You may want to consider a long position or call options on BBC as a result. In of 78 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where BBC advanced for three days, in of 289 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The 10-day RSI Indicator for BBC moved out of overbought territory on November 03, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 30 similar instances where the indicator moved out of overbought territory. In of the 30 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.

The Moving Average Convergence Divergence Histogram (MACD) for BBC turned negative on November 03, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 47 similar instances when the indicator turned negative. In of the 47 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where BBC declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

BBC broke above its upper Bollinger Band on October 15, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Arrowhead Pharmaceuticals (NASDAQ:ARWR).

Industry description

The investment seeks investment results that correspond, before fees and expenses, to the price and yield performance of the LifeSci Biotechnology Clinical Trials Index. Under normal market conditions, the fund will invest not less than 80% of its assets in component securities of the index. The index seeks to track the performance of the common stock of U.S. exchange-listed biotechnology companies with a primary product offering ("lead drug") that is typically in a Phase 1, Phase 2 or Phase 3 clinical trial stage of development, but prior to receiving marketing approval.

Market Cap

The average market capitalization across the Virtus LifeSci Biotech Clinical Trls ETF ETF is 2.02B. The market cap for tickers in the group ranges from 76.57M to 14.01B. SMMT holds the highest valuation in this group at 14.01B. The lowest valued company is IGMS at 76.57M.

High and low price notable news

The average weekly price growth across all stocks in the Virtus LifeSci Biotech Clinical Trls ETF ETF was 130%. For the same ETF, the average monthly price growth was 239%, and the average quarterly price growth was 711%. COGT experienced the highest price growth at 145%, while NTLA experienced the biggest fall at -30%.

Volume

The average weekly volume growth across all stocks in the Virtus LifeSci Biotech Clinical Trls ETF ETF was -26%. For the same stocks of the ETF, the average monthly volume growth was -4% and the average quarterly volume growth was 18%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 56
P/E Growth Rating: 79
Price Growth Rating: 47
SMR Rating: 94
Profit Risk Rating: 89
Seasonality Score: 11 (-100 ... +100)
View a ticker or compare two or three
BBC
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Category Health

Profile
Fundamentals
Details
Category
Health
Address
501 Madison Avenue, Suite 501New YorkNew York
Phone
(212) 593-4383
Web
N/A